Analyst Recommendation Trends
Wall Street analyst consensus for CYTK over the last few months:
Latest CYTK News
Will Camzyos Growth Keep Driving BMY's Cardiovascular Portfolio?
Bristol Myers' Camzyos gains a broader FDA label and strong sales growth, while emerging competitors and pipeline setbacks shape its cardiovascular outlook.
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four upcoming presentations, including two Late Breaking Clinical Research presentations and two oral presentations, at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2026 taking place in Phoenix, AZ from October 9 – 12, 2026. Late-Breaking Clinical Trial Presentations Title: Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Res
Lexicon Pharmaceuticals: Upgrading On Sotagliflozin HCM Data In Q1 '27 And More
Lexicon Pharmaceuticals, Inc. upgraded to Buy as multiple near-term catalysts emerge across its pipeline. Click for this updated look at LXRX.
Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Multi-center Prospective Study to Track Real-World Safety, Clinical Effectiveness, and Healthcare Resource Impact of MYQORZO in Routine Clinical Practice SOUTH SAN FRANCISCO, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the start of ASPEN-HCM (Aficamten Study of Patient Experience and Novel Outcomes in Symptomatic Obstructive HCM), a prospective, multicenter, observational real-world study evaluating MYQORZO® (aficamten) in adult patients w
Cytokinetics Begins ASPEN-HCM Study Evaluating MYQORZO In Adult Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
MYQORZO is a once-daily, oral allosteric and reversible inhibitor of cardiac myosin motor activity. In patients with oHCM, myosin inhibition with MYQORZO reduces cardiac contractility and left ventricular outflow tract
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach
B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.
Cytokinetics Maps MYQORZO Expansion, Heart Failure Pipeline at Bernstein Conference
Cytokinetics (NASDAQ:CYTK) executives outlined the company’s commercial expansion plans, cardiovascular pipeline and business-development priorities during a Bernstein investor symposium, highlighting the launch of MYQORZO and clinical programs targeting several forms of heart failure. Isaac Ciecha
Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story?
Polaris Capital Management, an investment management company, released its second-quarter 2026 investor letter for “Global Equity Strategy”. The letter can be downloaded here. Global markets delivered strong gains during the quarter, supported by an AI-driven earnings rally despite elevated interest rates, inflation concerns, and geopolitical uncertainty. Polaris Global Equity Composite (net of fees) returned 13.26% […]
Here’s How Much You Would Have Made Owning Cytokinetics Stock In The Last 15 Years
Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 15 years by 2.64% on an annualized basis producing an average annual return of 15.99%. Currently, Cytokinetics has a market capitalization of $9.70
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on September 15, 2026 it granted stock options to purchase an aggregate of 52,834 shares of common stock and 35,025 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 23 employees, whose employment commenced in August and September 2026 as a material inducement to their employment. The RSUs will vest over 3 years, with 40% of the
Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program
Program Provides Communications and Outreach Support for Patient Advocacy Organizations Focused on Cardiovascular Diseases Deadline for Applications is October 2, 2026 SOUTH SAN FRANCISCO, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced a call for proposals for the ninth annual Cytokinetics Communications Grant Program. The program will award a number of grants to patient advocacy organizations serving the hypertrophic cardiomyopathy (HCM) and
Cytokinetics, Incorporated (CYTK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Cytokinetics, Incorporated (CYTK) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 7:45 AM EDTCompany ParticipantsRobert I.
Cytokinetics: Why Myqorzo Doesn't Make Me A Buyer Yet
Cytokinetics, Incorporated stock faces pressure as Myqorzo sales jump 427% and NEJM Phase 3 data show efficacy vs. Camzyosâplus LVEF risk. Click for more on CYTK stock.
If You Invested $1000 In Cytokinetics Stock 10 Years Ago, You Would Have This Much Today
Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 10.3% on an annualized basis producing an average annual return of 23.89%. Currently, Cytokinetics has a market capitalization of $10.16
Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says
Cytokinetics (CYTK) likely has the upper hand in its patent dispute with Bristol-Myers Squibb (BMY)
Cytokinetics, Incorporated (CYTK) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
Cytokinetics, Incorporated (CYTK) Citigroup's Biopharma Back to School Summit 2026 September 9, 2026 3:00 PM EDTCompany ParticipantsRobert I.
Could Aficamten Give Cytokinetics the First Approved nHCM Treatment?
Cytokinetics, Incorporated (NASDAQ:CYTK) has reported detailed late-stage results that could support an expansion of aficamten into a form of genetic heart disease that currently does not have any approved treatments. Aficamten is already approved under the brand name Myqorzo for obstructive hypertrophic cardiomyopathy, or oHCM, in which thickened heart muscle restricts blood flow. Cytokinetics (NASDAQ:CYTK) […]
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-28 | Blum Robert I | -7,500 | - | - |
| 2026-09-28 | Blum Robert I | -7,500 | $65.46 | $490,950 |
| 2026-09-28 | Blum Robert I | +7,500 | $10.6 | $79,500 |
| 2026-09-22 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-09-22 | Malik Fady Ibraham | -3,500 | $68.29 | $239,015 |
| 2026-09-22 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-09-15 | Landry Robert E | -1,000 | $72.13 | $72,130 |
| 2026-09-15 | Blum Robert I | -97,926 | $69.33 | $6,789,210 |
| 2026-09-14 | Blum Robert I | -7,500 | - | - |
| 2026-09-14 | Blum Robert I | +97,926 | - | - |
| 2026-09-14 | Blum Robert I | -97,926 | - | - |
| 2026-09-14 | Blum Robert I | -1,350 | - | - |
| 2026-09-14 | Blum Robert I | -7,500 | $73.44 | $550,800 |
| 2026-09-14 | Blum Robert I | +7,500 | $10.6 | $79,500 |
| 2026-09-11 | Landry Robert E | -1,000 | $74.66 | $74,660 |
| 2026-09-08 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-09-08 | Malik Fady Ibraham | -3,500 | $75.46 | $264,110 |
| 2026-09-08 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-09-01 | PARSHALL B LYNNE | -5,000 | $71.48 | $357,400 |
| 2026-08-31 | Callos Andrew | -10,000 | - | - |
| 2026-08-31 | Callos Andrew | -10,000 | $70.24 | $702,400 |
| 2026-08-31 | Callos Andrew | +10,000 | $23.26 | $232,600 |
| 2026-08-31 | Blum Robert I | -7,500 | - | - |
| 2026-08-31 | Blum Robert I | -7,500 | $70.24 | $526,800 |
| 2026-08-31 | Blum Robert I | +7,500 | $10.6 | $79,500 |
| 2026-08-18 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-08-18 | Malik Fady Ibraham | -3,500 | $75.82 | $265,370 |
| 2026-08-18 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-08-10 | Blum Robert I | -7,500 | - | - |
| 2026-08-10 | Blum Robert I | -7,500 | $76.76 | $575,700 |
| 2026-08-10 | Blum Robert I | +7,500 | $10.6 | $79,500 |
| 2026-07-30 | Callos Andrew | -14,000 | - | - |
| 2026-07-30 | Callos Andrew | -14,000 | $79.88 | $1,118,320 |
| 2026-07-30 | Callos Andrew | +14,000 | $23.26 | $325,640 |
| 2026-07-27 | Blum Robert I | -7,500 | - | - |
| 2026-07-27 | Blum Robert I | -7,500 | $80.87 | $606,525 |
| 2026-07-27 | Blum Robert I | +7,500 | $10.6 | $79,500 |
| 2026-07-21 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-07-21 | Malik Fady Ibraham | -3,500 | $80.59 | $282,065 |
| 2026-07-21 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-07-15 | Wysenski Nancy | +75 | $82.62 | $6,197 |
| 2026-07-15 | WIERENGA WENDELL | +75 | $82.62 | $6,197 |
| 2026-07-15 | Kaye Edward M. MD | +151 | $82.62 | $12,476 |
| 2026-07-15 | HENDERSON JOHN T | +272 | $82.62 | $22,473 |
| 2026-07-15 | Harrington Robert Arthur | +151 | $82.62 | $12,476 |
| 2026-07-15 | Daly James M | +151 | $82.62 | $12,476 |
| 2026-07-13 | Blum Robert I | -7,490 | - | - |
| 2026-07-13 | Blum Robert I | -7,490 | $82.02 | $614,330 |
| 2026-07-13 | Blum Robert I | +7,490 | $10.6 | $79,394 |
| 2026-07-13 | Blum Robert I | -10 | $82.02 | $820 |
| 2026-07-07 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-07-07 | Malik Fady Ibraham | -3,500 | $86.62 | $303,170 |
| 2026-07-07 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-07-01 | Blum Robert I | -7,500 | $84.92 | $636,900 |
| 2026-07-01 | Callos Andrew | -15,000 | - | - |
| 2026-07-01 | Callos Andrew | -15,000 | $85.8 | $1,287,000 |
| 2026-07-01 | Callos Andrew | +15,000 | $23.26 | $348,900 |
| 2026-07-01 | Lee Sung | -1,112 | - | - |
| 2026-07-01 | Lee Sung | -1,112 | $87.79 | $97,622 |
| 2026-07-01 | Lee Sung | +1,112 | $48.51 | $53,943 |
| 2026-06-23 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-06-23 | Malik Fady Ibraham | -3,500 | $79.51 | $278,285 |
| 2026-06-23 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-06-15 | Blum Robert I | -7,500 | $70.46 | $528,450 |
| 2026-06-09 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-06-09 | Malik Fady Ibraham | -3,500 | $67.98 | $237,930 |
| 2026-06-09 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-06-01 | Kaye Edward M. MD | -2,933 | $76.09 | $223,172 |
| 2026-06-01 | Callos Andrew | -15,000 | - | - |
| 2026-06-01 | Callos Andrew | -15,000 | $74.08 | $1,111,200 |
| 2026-06-01 | Callos Andrew | +15,000 | $23.26 | $348,900 |
| 2026-06-01 | PARSHALL B LYNNE | -5,000 | $74.08 | $370,400 |
| 2026-05-27 | Blum Robert I | -7,500 | $77.21 | $579,075 |
| 2026-05-27 | Bhanji Muna | +4,301 | - | - |
| 2026-05-27 | Bhanji Muna | +2,851 | - | - |
| 2026-05-27 | Daly James M | +4,301 | - | - |
| 2026-05-27 | Daly James M | +2,851 | - | - |
| 2026-05-27 | Harrington Robert Arthur | +4,301 | - | - |
| 2026-05-27 | Harrington Robert Arthur | +2,851 | - | - |
| 2026-05-27 | HENDERSON JOHN T | +4,301 | - | - |
| 2026-05-27 | HENDERSON JOHN T | +2,851 | - | - |
| 2026-05-27 | Kaye Edward M. MD | +4,301 | - | - |
| 2026-05-27 | Kaye Edward M. MD | +2,851 | - | - |
| 2026-05-27 | PARSHALL B LYNNE | +4,301 | - | - |
| 2026-05-27 | PARSHALL B LYNNE | +2,851 | - | - |
| 2026-05-27 | Landry Robert E | +4,301 | - | - |
| 2026-05-27 | Landry Robert E | +2,851 | - | - |
| 2026-05-27 | WIERENGA WENDELL | +4,301 | - | - |
| 2026-05-27 | WIERENGA WENDELL | +2,851 | - | - |
| 2026-05-27 | Wysenski Nancy | +4,301 | - | - |
| 2026-05-27 | Wysenski Nancy | +2,851 | - | - |
| 2026-05-19 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-05-19 | Malik Fady Ibraham | -3,500 | $75.69 | $264,915 |
| 2026-05-19 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-05-14 | Blum Robert I | -7,500 | $77.92 | $584,400 |
| 2026-05-05 | HENDERSON JOHN T | -20,000 | - | - |
| 2026-05-05 | HENDERSON JOHN T | -20,000 | $75.97 | $1,519,400 |
| 2026-05-05 | HENDERSON JOHN T | +20,000 | $7.61 | $152,200 |
| 2026-05-05 | Callos Andrew | -11,333 | - | - |
| 2026-05-05 | Callos Andrew | -11,333 | $77.25 | $875,474 |
| 2026-05-05 | Callos Andrew | +11,333 | $39.13 | $443,460 |
| 2026-05-05 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-05-05 | Malik Fady Ibraham | -3,500 | $77.37 | $270,795 |
| 2026-05-05 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-05-05 | WIERENGA WENDELL | -4,032 | - | - |
| 2026-05-05 | WIERENGA WENDELL | -4,032 | $75 | $302,400 |
| 2026-05-05 | WIERENGA WENDELL | +4,032 | $12.4 | $49,997 |
| 2026-05-05 | Lee Sung | -23,906 | $76.87 | $1,837,654 |
| 2026-05-01 | Callos Andrew | -15,857 | - | - |
| 2026-05-01 | Callos Andrew | -15,857 | $65 | $1,030,705 |
| 2026-05-01 | Callos Andrew | +15,857 | $37.63 | $596,699 |
| 2026-04-30 | Callos Andrew | -15,000 | - | - |
| 2026-04-30 | Callos Andrew | -15,000 | $63.26 | $948,900 |
| 2026-04-30 | Callos Andrew | +15,000 | $23.26 | $348,900 |
| 2026-04-29 | Blum Robert I | -7,500 | $59.62 | $447,150 |
| 2026-04-21 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-04-21 | Malik Fady Ibraham | -3,500 | $65.69 | $229,915 |
| 2026-04-21 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-04-15 | Wysenski Nancy | +95 | $65.37 | $6,210 |
| 2026-04-15 | WIERENGA WENDELL | +95 | $65.37 | $6,210 |
| 2026-04-15 | Kaye Edward M. MD | +191 | $65.37 | $12,486 |
| 2026-04-15 | HENDERSON JOHN T | +325 | $65.37 | $21,245 |
| 2026-04-15 | Harrington Robert Arthur | +191 | $65.37 | $12,486 |
| 2026-04-15 | Daly James M | +191 | $65.37 | $12,486 |
| 2026-04-15 | Callos Andrew | -7,449 | $66.02 | $491,783 |
| 2026-04-15 | Blum Robert I | -7,500 | $65.38 | $490,350 |
| 2026-04-07 | Malik Fady Ibraham | -1,000 | - | - |
| 2026-04-07 | Malik Fady Ibraham | -3,500 | - | - |
| 2026-04-07 | Malik Fady Ibraham | -1,000 | $64.75 | $64,750 |
| 2026-04-07 | Malik Fady Ibraham | +1,000 | $10.6 | $10,600 |
| 2026-04-07 | Malik Fady Ibraham | -3,500 | $65.21 | $228,235 |
| 2026-04-07 | Malik Fady Ibraham | +3,500 | $7.8 | $27,300 |
| 2026-04-01 | Blum Robert I | -7,500 | $66.63 | $499,725 |
| 2026-03-31 | Callos Andrew | -3,639 | $65 | $236,535 |
| 2026-03-18 | Callos Andrew | -1,930 | $62.07 | $119,795 |
| 2026-03-17 | Lee Sung | -4,935 | $62.15 | $306,710 |
| 2026-03-17 | Callos Andrew | -2,916 | $62.15 | $181,229 |
| 2026-03-17 | Callos Andrew | -5,626 | $62.15 | $349,656 |
| 2026-03-17 | Malik Fady Ibraham | -4,397 | $62.15 | $273,274 |
| 2026-03-17 | Malik Fady Ibraham | -7,636 | $62.15 | $474,577 |
| 2026-03-17 | Blum Robert I | -23,928 | $62.15 | $1,487,125 |
| 2026-03-17 | Blum Robert I | -12,673 | $62.15 | $787,627 |
| 2026-03-16 | Callos Andrew | -1,709 | $61.03 | $104,300 |
| 2026-03-15 | Blum Robert I | +111,864 | - | - |
| 2026-03-15 | Blum Robert I | +1,665 | - | - |
| 2026-03-15 | Blum Robert I | +75,258 | - | - |
| 2026-03-15 | Callos Andrew | +29,480 | - | - |
| 2026-03-15 | Callos Andrew | +1,665 | - | - |
| 2026-03-15 | Callos Andrew | +13,320 | - | - |
| 2026-03-15 | Callos Andrew | +20,646 | - | - |
| 2026-03-15 | Hessekiel Jeffrey | +22,820 | - | - |
| 2026-03-15 | Hessekiel Jeffrey | +8,325 | - | - |
| 2026-03-15 | Hessekiel Jeffrey | +20,646 | - | - |
| 2026-03-15 | Lee Sung | +29,480 | - | - |
| 2026-03-15 | Lee Sung | +1,665 | - | - |
| 2026-03-15 | Lee Sung | +20,646 | - | - |
| 2026-03-15 | Malik Fady Ibraham | +39,527 | - | - |
| 2026-03-15 | Malik Fady Ibraham | +1,665 | - | - |
| 2026-03-15 | Malik Fady Ibraham | +27,306 | - | - |
| 2026-03-09 | Callos Andrew | -2,582 | $60.72 | $156,779 |
| 2026-03-09 | Malik Fady Ibraham | -2,907 | $60.72 | $176,513 |
| 2026-03-09 | Blum Robert I | -7,931 | $60.72 | $481,570 |
| 2026-03-05 | Callos Andrew | -15,000 | - | - |
| 2026-03-05 | Callos Andrew | -11,000 | - | - |
| 2026-03-05 | Callos Andrew | +15,000 | $23.26 | $348,900 |
| 2026-03-05 | Callos Andrew | -11,000 | $61.88 | $680,680 |
| 2026-03-05 | Callos Andrew | -15,000 | $61.87 | $928,050 |
| 2026-03-05 | Callos Andrew | +11,000 | $39.13 | $430,430 |
| 2026-03-02 | PARSHALL B LYNNE | -5,000 | $61.21 | $306,050 |
| 2026-03-02 | Callos Andrew | -886 | - | - |
| 2026-03-02 | Callos Andrew | -886 | $61.62 | $54,595 |
| 2026-03-02 | Callos Andrew | +886 | $37.63 | $33,340 |
| 2026-02-05 | Callos Andrew | -15,000 | - | - |
| 2026-02-05 | Callos Andrew | -15,000 | $61.93 | $928,950 |
| 2026-02-05 | Callos Andrew | +15,000 | $23.26 | $348,900 |
| 2026-02-02 | Callos Andrew | -886 | - | - |
| 2026-02-02 | Callos Andrew | -886 | $62.1 | $55,021 |
| 2026-02-02 | Callos Andrew | +886 | $37.63 | $33,340 |
| 2026-01-15 | Daly James M | +197 | $63.44 | $12,498 |
| 2026-01-15 | Wysenski Nancy | +98 | $63.44 | $6,217 |
| 2026-01-15 | WIERENGA WENDELL | +98 | $63.44 | $6,217 |
| 2026-01-15 | Kaye Edward M. MD | +197 | $63.44 | $12,498 |
| 2026-01-15 | HENDERSON JOHN T | +334 | $63.44 | $21,189 |
| 2026-01-15 | Harrington Robert Arthur | +197 | $63.44 | $12,498 |
| 2026-01-05 | Callos Andrew | -15,000 | - | - |
| 2026-01-05 | Callos Andrew | -15,000 | $60.28 | $904,200 |
| 2026-01-05 | Callos Andrew | +15,000 | $23.26 | $348,900 |
| 2026-01-02 | Callos Andrew | -885 | - | - |
| 2026-01-02 | Callos Andrew | -885 | $63.16 | $55,897 |
| 2026-01-02 | Callos Andrew | +885 | $37.63 | $33,303 |
| 2026-01-02 | Callos Andrew | -913 | $62.09 | $56,688 |
| 2025-12-29 | Callos Andrew | -1,809 | $62.44 | $112,954 |
| 2025-12-22 | Blum Robert I | -2,935 | $62.72 | $184,083 |
| 2025-12-22 | Blum Robert I | +5,765 | - | - |
| 2025-12-22 | Blum Robert I | +5,765 | - | - |
| 2025-12-22 | Malik Fady Ibraham | -1,016 | $62.72 | $63,724 |
| 2025-12-22 | Malik Fady Ibraham | +2,000 | - | - |
| 2025-12-22 | Malik Fady Ibraham | +2,000 | - | - |
| 2025-12-22 | Callos Andrew | -675 | $62.72 | $42,336 |
| 2025-12-22 | Callos Andrew | +1,588 | - | - |
| 2025-12-22 | Callos Andrew | +1,589 | - | - |
| 2025-12-22 | Lee Sung | -805 | $62.72 | $50,490 |
| 2025-12-22 | Lee Sung | +2,152 | - | - |
| 2025-12-22 | Lee Sung | +2,152 | - | - |
| 2025-12-22 | Blum Robert I | -16,506 | - | - |
| 2025-12-22 | Blum Robert I | -54,727 | - | - |
| 2025-12-22 | Blum Robert I | +16,506 | $6.67 | $110,095 |
| 2025-12-22 | Blum Robert I | -30,426 | $68.18 | $2,074,445 |
| 2025-12-22 | Blum Robert I | +54,727 | $6.67 | $365,029 |
| 2025-12-22 | WIERENGA WENDELL | -20,000 | - | - |
| 2025-12-22 | WIERENGA WENDELL | -20,000 | $66.14 | $1,322,800 |
| 2025-12-22 | WIERENGA WENDELL | +20,000 | $7.61 | $152,200 |
| 2025-12-16 | Malik Fady Ibraham | -2,200 | - | - |
| 2025-12-16 | Malik Fady Ibraham | -2,200 | $61.24 | $134,728 |
| 2025-12-16 | Malik Fady Ibraham | +2,200 | $10.6 | $23,320 |
| 2025-12-08 | Callos Andrew | -1,042 | - | - |
| 2025-12-08 | Callos Andrew | -1,042 | $65.96 | $68,730 |
| 2025-12-08 | Callos Andrew | +1,042 | $39.13 | $40,773 |
| 2025-12-05 | Callos Andrew | -10,628 | - | - |
| 2025-12-05 | Callos Andrew | -15,858 | - | - |
| 2025-12-05 | Callos Andrew | -11,000 | - | - |
| 2025-12-05 | Callos Andrew | -15,000 | - | - |
| 2025-12-05 | Callos Andrew | -52,486 | $65.95 | $3,461,452 |
| 2025-12-05 | Callos Andrew | +10,628 | $37.63 | $399,932 |
| 2025-12-05 | Callos Andrew | +15,858 | $37.63 | $596,737 |
| 2025-12-05 | Callos Andrew | +11,000 | $39.13 | $430,430 |
| 2025-12-05 | Callos Andrew | +15,000 | $23.26 | $348,900 |
| 2025-12-03 | Lee Sung | -1,560 | $65.02 | $101,431 |
| 2025-12-03 | Callos Andrew | -1,368 | $65.02 | $88,947 |
| 2025-12-03 | Malik Fady Ibraham | -2,058 | $65.02 | $133,811 |
| 2025-12-03 | Blum Robert I | -5,930 | $65.02 | $385,569 |
| 2025-12-02 | HENDERSON JOHN T | -8,750 | - | - |
| 2025-12-02 | HENDERSON JOHN T | -8,750 | $63.9 | $559,125 |
| 2025-12-02 | HENDERSON JOHN T | +8,750 | $10 | $87,500 |
| 2025-12-02 | Malik Fady Ibraham | -2,200 | - | - |
| 2025-12-02 | Malik Fady Ibraham | -2,200 | $63.89 | $140,558 |
| 2025-12-02 | Malik Fady Ibraham | +2,200 | $10.6 | $23,320 |
| 2025-12-01 | Kaye Edward M. MD | -20,000 | - | - |
| 2025-12-01 | Kaye Edward M. MD | -8,064 | - | - |
| 2025-12-01 | Kaye Edward M. MD | -28,064 | $66.72 | $1,872,430 |
| 2025-12-01 | Kaye Edward M. MD | +20,000 | $14.25 | $285,000 |
| 2025-12-01 | Kaye Edward M. MD | +8,064 | $12.4 | $99,994 |
| 2025-12-01 | Harrington Robert Arthur | -2,150 | $66.8 | $143,620 |
| 2025-11-19 | PARSHALL B LYNNE | -5,000 | $64.73 | $323,650 |
| 2025-11-18 | Malik Fady Ibraham | -2,200 | - | - |
| 2025-11-18 | Malik Fady Ibraham | -2,200 | $66.45 | $146,190 |
| 2025-11-18 | Malik Fady Ibraham | +2,200 | $10.6 | $23,320 |
| 2025-11-14 | Hessekiel Jeffrey | +87,297 | - | - |
| 2025-11-11 | Kaye Edward M. MD | -5,175 | - | - |
| 2025-11-11 | Kaye Edward M. MD | -5,175 | $65.08 | $336,789 |
| 2025-11-11 | Kaye Edward M. MD | +5,175 | $9.66 | $49,991 |
| 2025-11-05 | Blum Robert I | -2,000 | - | - |
| 2025-11-04 | Malik Fady Ibraham | -2,295 | - | - |
| 2025-11-04 | Malik Fady Ibraham | -2,295 | $59.55 | $136,667 |
| 2025-11-04 | Malik Fady Ibraham | +2,295 | $10.6 | $24,327 |
| 2025-10-30 | Blum Robert I | -5,000 | $62.86 | $314,300 |
| 2025-10-27 | WIERENGA WENDELL | -4,375 | - | - |
| 2025-10-27 | WIERENGA WENDELL | -4,375 | $58.68 | $256,725 |
| 2025-10-27 | WIERENGA WENDELL | +4,375 | $10 | $43,750 |
| 2025-10-21 | Malik Fady Ibraham | -2,105 | - | - |
| 2025-10-21 | Malik Fady Ibraham | -2,105 | $58.22 | $122,553 |
| 2025-10-21 | Malik Fady Ibraham | +2,105 | $10.6 | $22,313 |
| 2025-10-16 | Blum Robert I | -5,000 | $60.03 | $300,150 |
| 2025-10-15 | WIERENGA WENDELL | +99 | $62.8 | $6,217 |
| 2025-10-15 | Harrington Robert Arthur | +199 | $62.8 | $12,497 |
| 2025-10-15 | HENDERSON JOHN T | +338 | $62.8 | $21,226 |
| 2025-10-15 | Kaye Edward M. MD | +199 | $62.8 | $12,497 |
| 2025-10-15 | Wysenski Nancy | +99 | $62.8 | $6,217 |
| 2025-10-07 | Malik Fady Ibraham | -2,000 | - | - |
| 2025-10-07 | Malik Fady Ibraham | -2,000 | $60.56 | $121,120 |
| 2025-10-07 | Malik Fady Ibraham | +2,000 | $10.6 | $21,200 |
| 2025-10-06 | Kaye Edward M. MD | -6,757 | $60 | $405,420 |